Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

       
Total article views   HTML views PDF downloads Totals
12,305 Dovepress* 10,557+ 2,068 12,625
PubMed Central* 1,748 560 2,308
Totals 12,305 2,628 14,933
*Since 17 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar